Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment

Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Med Ethics
Main Authors: Henderson, Gail E, Peay, Holly L, Kroon, Eugene, Cadigan, Rosemary Jean, Meagher, Karen, Jupimai, Thidarat, Gilbertson, Adam, Fisher, Jill, Ormsby, Nuchanart Q, Chomchey, Nitiya, Phanuphak, Nittaya, Ananworanich, Jintanat, Rennie, Stuart
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Research Ethics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5869463/
https://ncbi.nlm.nih.gov/pubmed/29127137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/medethics-2017-104433
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados